Immediate Impact
59 standout
Citing Papers
Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
2025 Standout
Tailoring traditional Chinese medicine in cancer therapy
2025 Standout
Works of Nuy Chau being referenced
Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: Implications for hyperbilirubinemia
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Nuy Chau | 185 | 143 | 132 | 149 | 15 | 496 | |
| Barton Cobert | 258 | 72 | 129 | 37 | 13 | 533 | |
| Suphat Subongkot | 86 | 65 | 51 | 71 | 21 | 456 | |
| Zhong‐ning Zhu | 38 | 160 | 95 | 40 | 14 | 510 | |
| Lise Eliot | 95 | 75 | 99 | 129 | 18 | 527 | |
| Donald Stanski | 55 | 91 | 48 | 38 | 15 | 489 | |
| Evangelia Eirini Tsermpini | 173 | 94 | 25 | 49 | 26 | 501 | |
| William R. Sterling | 44 | 204 | 51 | 57 | 11 | 418 | |
| J. Wemer | 130 | 191 | 49 | 67 | 29 | 550 | |
| AF Cohen | 45 | 55 | 52 | 35 | 15 | 431 | |
| Maria Blonda | 57 | 197 | 32 | 73 | 16 | 515 |
All Works
Login with ORCID to disown or claim papers
Loading papers...